NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases
Authors:
Open Access
- 15 December 2023
- journal article
- review article
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 19 (9) , 1961-1966
Abstract
Diseases like Alzheimer's and Parkinson's diseases are defined by inflammation and the damage neurons undergo due to oxidative stress. A primary reactive oxygen species contributor in the central nervous system, NADPH oxidase 4, is viewed as a potential therapeutic touchstone and indicative marker for these ailments. This in-depth review brings to light distinct features of NADPH oxidase 4, responsible for generating superoxide and hydrogen peroxide, emphasizing its pivotal role in activating glial cells, inciting inflammation, and disturbing neuronal functions. Significantly, malfunctioning astrocytes, forming the majority in the central nervous system, play a part in advancing neurodegenerative diseases, due to their reactive oxygen species and inflammatory factor secretion. Our study reveals that aiming at NADPH oxidase 4 within astrocytes could be a viable treatment pathway to reduce oxidative damage and halt neurodegenerative processes. Adjusting NADPH oxidase 4 activity might influence the neuroinflammatory cytokine levels, including myeloperoxidase and osteopontin, offering better prospects for conditions like Alzheimer's disease and Parkinson's disease. This review sheds light on the role of NADPH oxidase 4 in neural degeneration, emphasizing its drug target potential, and paving the path for novel treatment approaches to combat these severe conditions.Keywords
This publication has 108 references indexed in Scilit:
- Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astrogliaGlia, 2012
- Cognitive impairment in humanized APP×PS1 mice is linked to Aβ1–42 and NOX activationNeurobiology of Disease, 2011
- Dysregulation of astrocyte–motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosisBrain, 2011
- NADPH-oxidase activation and cognition in Alzheimer disease progressionFree Radical Biology and Medicine, 2011
- Upregulation of Nox4 by Hypertrophic Stimuli Promotes Apoptosis and Mitochondrial Dysfunction in Cardiac MyocytesCirculation Research, 2010
- Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in SynucleinopathiesJournal of Biological Chemistry, 2010
- Subcellular localization of Nox4 and regulation in diabetesProceedings of the National Academy of Sciences, 2009
- Poldip2, a Novel Regulator of Nox4 and Cytoskeletal Integrity in Vascular Smooth Muscle CellsCirculation Research, 2009
- The induction of HIF‐1 reduces astrocyte activation by amyloid beta peptideEuropean Journal of Neuroscience, 2009
- Aberrant Expression of Myeloperoxidase in Astrocytes Promotes Phospholipid Oxidation and Memory Deficits in a Mouse Model of Alzheimer DiseaseJournal of Biological Chemistry, 2009